Genteric
About:
Gene-based drug delivery company
Top Investors: MPM Capital, Alta Partners, Sanderling Ventures, MedVenture Associates, China Development Industrial Bank (CDIB)
Description:
Genteric, Inc. develops gene-based drug delivery that employs the secretor organs of the patient’s gastrointestinal system to produce and release therapeutic proteins into the bloodstream.
Total Funding Amount:
$31M
Headquarters Location:
Redwood City, California, United States
Founded Date:
1997-01-01
Founders:
David Olson, Ira Goldfiine
Number of Employees:
Last Funding Date:
2001-04-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai